Colorectal Neoplasms Clinical Trials

654 clinical trials for Colorectal Neoplasms across international registries, including 69 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Colonoscopy vs Stool Testing for Older Adults With Colon Polyps — RECRUITING · NA
• Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors — RECRUITING · PHASE1
• A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations — RECRUITING · PHASE1
• A Study of DM002 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer — RECRUITING
• A Study of LY4257496 in Participants With Cancer (OMNIRAY) — RECRUITING · PHASE1
• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — RECRUITING · PHASE1
• Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia — RECRUITING
• AI-Based Stool Image Analysis for Colorectal Neoplasia Risk Assessment — RECRUITING
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — RECRUITING · PHASE3
• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer — RECRUITING · PHASE3
• Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer — RECRUITING · PHASE3
• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer — RECRUITING · PHASE3
• A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors — RECRUITING · PHASE1
• A Novel Clinical Decision Support Tool to Predict Submucosal Invasive Cancer Within Large Non-Pedunculated Colorectal Polyps — RECRUITING
• PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma — RECRUITING · PHASE2
• Early Onset Colorectal Cancer Detection — RECRUITING
• Early Detection of Advanced Adenomas and Colorectal Cancer — RECRUITING
• A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers — RECRUITING · PHASE1
• A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors — RECRUITING · PHASE1
• Impact of SMS Messaging on Participation in Colorectal Cancer Screening — RECRUITING · NA
• A Study of LY4170156 in Participants With Selected Advanced Solid Tumors — RECRUITING · PHASE1
• Early Feeding Versus Delayed Feeding After Colorectal Endoscopic Submucosal Dissection — RECRUITING · NA
• A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC — RECRUITING · PHASE3
• AP-NOSES: A Prospective Multicentre Registry of Natural Orifice Specimen Extraction in Minimally Invasive Colorectal Surgery — RECRUITING
• PRIORITY-CONNECT 2 Trial — RECRUITING · NA
• A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer — RECRUITING · PHASE1
• Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy — RECRUITING · NA
• Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host — RECRUITING
• Epidemiological and Molecular Colorectal Cancer Registry — RECRUITING
• Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer — RECRUITING
• Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years. — RECRUITING · NA
• DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies — RECRUITING
• Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance — RECRUITING · NA
• DEXDES Trial: Dexmedetomidine-Desflurane Combination in Laparoscopic Colectomy — RECRUITING · NA
• Health Behavior Change in High-Risk Colorectal Cancer Individuals — RECRUITING · NA
• DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations — RECRUITING · PHASE2
• The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer — RECRUITING · PHASE2
• DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition — RECRUITING · PHASE2
• DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. — RECRUITING · PHASE2
• DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment — RECRUITING · PHASE4
• Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II) — RECRUITING · NA
• Smart Measurement of Circulating Tumor DNA — RECRUITING · NA
• Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status — RECRUITING · PHASE2
• A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers — RECRUITING · NA
• Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver — RECRUITING · PHASE3
• Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques — RECRUITING
• HTL0039732 in Participants With Advanced Solid Tumours — RECRUITING · PHASE1
• The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment — RECRUITING
• Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate — RECRUITING · NA

Refine this search